Jeff Yass’s BriaCell Therapeutics Warrant BCTXZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.9K Buy
287,547
+173,025
+151% +$21.4K ﹤0.01% 12833
2026
Q2
$11.5K Buy
+114,522
New +$11.1K ﹤0.01% 13113

Other funds holding BCTXZ

Jeff Yass's BCTXZ Position: Q3 2026 in Review

Jeff Yass increased its BriaCell Therapeutics Warrant (BCTXZ) stake by 151% in Q3 2026, buying an estimated $21.4K and bringing the position to 287,547 shares worth $56.9K. The position accounts for ﹤0.01% of the portfolio, ranked #12833.

Jeff Yass first reported a position in BCTXZ in Q2 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold BCTXZ as of Q3 2026.

  • Jeff Yass held 287,547 shares of BriaCell Therapeutics Warrant worth $56.9K as of Q3 2026.
  • Jeff Yass bought 173,025 BriaCell Therapeutics Warrant shares in Q3 2026, an estimated $21.4K.
  • BriaCell Therapeutics Warrant made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12833 holding.
  • Jeff Yass first reported a position in BriaCell Therapeutics Warrant in Q2 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held BriaCell Therapeutics Warrant as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.